Preoperative SGLT2 Inhibitor Use and Postoperative Diabetic Ketoacidosis
SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors
Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users
SGLT2 Inhibitors and External Genital Infection in Male Patients With Type 2 Diabetes
